Iantrek logo and byline tight.jpg
12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology
January 23, 2023 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Iantrek today announced the publication of 12-month clinical results of a novel bio-stenting procedure using the company’s microsurgical...
Featured Image for Olleyes
Olleyes, Inc. Achieves ISO Certification
January 12, 2023 09:00 ET | Olleyes
SUMMIT, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Olleyes, Inc. announced today that it has earned the International Organization for Standardization (ISO) 13485:2016 certification from SGS. The...
Global Dry Eye Products Market
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:26 ET | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
Global Dry Eye Products Market
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:24 ET | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
22157.jpg
Diabetic Macular Edema Treatment Global Market Report 2022: Intravitreal Implants Set to Take Center Stage
January 10, 2023 07:13 ET | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
New Logo.png
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
January 09, 2023 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...
Featured Image for Amber Ophthalmics, Inc.
Amber Ophthalmics Announces Positive Topline Phase 2 Data Evaluating NEXAGON® for the Treatment of Persistent Corneal Epithelial Defect (PCED)
January 09, 2023 07:31 ET | Amber Ophthalmics, Inc.
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Amber Ophthalmics, Inc. (Amber), a privately held clinical-stage biopharmaceutical company focused on developing innovative therapies for rare ophthalmic...
Ophthalmology PACS Market
Global Ophthalmology PACS Market Report to 2030 - Market Players are Involved in Advancing Technologies for Ophthalmic Care Driving Growth
December 27, 2022 05:18 ET | Research and Markets
Dublin, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market, by Type, by Delivery Model, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report...
Eyenovia
Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology
December 22, 2022 09:01 ET | Eyenovia
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) -- While medical devices have seen incredible advancements over the last 100 years, ocular drug delivery systems have seen minimal progress; the standard eye...
Robert van der Vaart, glaucoma expert
Wilmington Eye Ophthalmic Surgeon Implants First-Ever Glaucoma Device in the Carolinas
December 21, 2022 11:00 ET | Wilmington Eye
WILMINGTON, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Today, Wilmington Eye announced Dr. Robert van der Vaart, a board-certified ophthalmic surgeon and glaucoma expert, has successfully implanted the...